Resources | Press Releases |Press Release

Research and Markets (http://www.researchandmarkets.com/research/78f76e/the_pharmaceutical) has announced the addition of Frost & Sullivan's new report "The Pharmaceutical Industry in Botswana" to their offering.

This research service presents an in-depth analysis of the Botswana pharmaceutical industry. It provides a general insight into processes of regulations, medical insurance, healthcare procurement and financing. An analysis of key industry dynamics affecting each of pharmaceutical segments is presented, as well as industry sizes and growth rates over the period 2008-2015. In addition, a thorough competitor analysis for each industry was performed.

This Frost & Sullivan research service titled The Pharmaceutical Industry in Botswana provides growth forecasts, competitor analysis and market dynamics. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: generic and branded pharmaceuticals.

Market Overview

PPPs to Support Expansion of Pharmaceutical Industry in Botswana

Botswana does not yet have a pharmaceutical manufacturing industry and thus, all drugs are imported. In an attempt to improve accessibility to essential medication and diversify economic activity, the government is launching private-public partnership (PPP) initiatives to kick-start local pharmaceutical production. Through government-backed PPPs, the expectation is that prices would come down as a result of the availability of locally manufactured generic drugs, notes the analyst of this research. Lack of technical capability has been one of the main deterrents to local drug production, although the trend towards partnering Indian and Thai generic drug makers should, in the medium- to long-term, help ease this constraint.

Increased availability of low-cost generic drugs is poised to drive uptake of drugs. As patents on major drugs are expiring, the availability of generic alternatives in Botswana is on the rise. Mass treatment programmes which had relied on donated branded drugs are now switching to cheaper generic versions, states the analyst. Local production of generic drugs, once in place, is set to expand coverage of these mass roll-out programmes.

Low-cost Generic Drugs to Experience Wider Adoption

The pharmaceutical market in Botswana presents significant opportunities for manufacturers of low-cost generic drugs. Infectious diseases, such as HIV/AIDS and malaria, are receiving heightened attention from donors, who are mostly looking to procure generic alternatives compared to the more costly branded products. This trend has been made more important in the current economic climate, as donor organisations seek to contain costs, as they are face uncertainty in terms of flow of funds.

The main restraint to market growth is the high cost of imported drugs due to unavailability of cheaper, locally manufactured alternatives, remarks the analyst. Wider availability of locally manufactured drugs should drive prices down and improve affordability. Generic drugs are low-cost and local production would expand accessibility to essential medication. The lack of technical skills is the main deterrent to local production. However, overseas companies mostly from Asia Pacific - are seeking to enter strategic partnerships with local firms that are likely to enable local pharmaceutical production.

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

• Generic pharmaceuticals
• Branded pharmaceuticals

Key Topics Covered:

1. Table of Contents

2. Executive Summary

3. Research, Aim and Objectives

4. Overview of the Healthcare Industry

5. Pharmaceuticals Industry

6. Generic Drugs Market

7. Branded Drugs Market

8. Strategic Recommendations

9. About Frost & Sullivan

For more information visit http://www.researchandmarkets.com/research/78f76e/the_pharmaceutical